Results for tag: "AMPA Receptor Antagonist"

The AMPA Receptor Antagonist market is a subset of the Central Nervous System Drugs market. It is composed of drugs that act on the AMPA receptor, a type of ionotropic glutamate receptor found in the central nervous system. These drugs are used to treat a variety of neurological conditions, including epilepsy, Alzheimer's disease, and Parkinson's disease. They are also used to treat depression, anxiety, and other psychiatric disorders. AMPA receptor antagonists are typically administered orally, intravenously, or intramuscularly. The AMPA Receptor Antagonist market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Sanofi. Other companies in the market include AstraZeneca, Eli Lilly, and Johnson & Johnson. Show Less Read more